SARS News and Research

RSS

2025 Chikungunya outbreak: A global health challenge

Chikungunya virus (CHIKV) is a mosquito-borne alphavirus causing fever, severe joint pain, rash, and muscle aches, mainly transmitted by Aedes mosquitoes. As of 2025,

From Sino Biological Inc. 18 Aug 2025

Respiratory viruses awaken dormant breast cancer cells and raise relapse risk

Respiratory viruses such as influenza and COVID-19 can reactivate dormant breast cancer cells in the lungs, raising the risk of metastasis. The process is driven by IL-6–induced cell changes and immune suppression, with the highest recurrence risk soon after infection.

14 Aug 2025

COVID-19 increases risk of asthma and sinusitis while vaccination offers protection

People who have had COVID-19 are at increased risk of developing certain inflammatory diseases of the airways, such as asthma, hay fever and chronic sinusitis.

14 Aug 2025

Llama-derived nanobody VHH21 destroys the spike-trimer of SARS-CoV-2

Neutralizing antibodies that merely block receptor binding are losing ground against heavily mutated SARS-CoV-2 Omicron sub-variants.

14 Aug 2025

Rare immune mutation unlocks universal antiviral protection

For a few dozen people in the world, the downside of living with a rare immune condition comes with a surprising superpower-the ability to fight off all viruses.

14 Aug 2025

New diagnostic tool offers rapid, low-cost blood test for multiple diseases

Researchers at Arizona State University have developed a breakthrough diagnostic tool that could transform how quickly and reliably we detect illnesses like COVID-19, Ebola, AIDS or Lyme disease. The test uses just a single drop of blood, costs a couple of dollars and delivers results in only 15 minutes.

13 Aug 2025

Long COVID linked to lasting financial hardship and work disruption

While the economic impact of the COVID-19 pandemic continues to be widely studied and debated, the financial toll of the COVID-19 pandemic for individual patients is less understood.

12 Aug 2025

Study: Lignin shows strong antiviral and antibacterial properties

Research from the Nanoscience Center of the University of Jyväskylä, Finland, has revealed that lignin, a polyphenol, important for plant structure, has antimicrobial activity against viruses and bacteria.

12 Aug 2025

Synthetic sugar-coated nanoparticle blocks Covid-19 from infecting human cells

Groundbreaking research led by a Swansea University academic has revealed a synthetic glycosystem - a sugar-coated polymer nanoparticle - that can block Covid-19 from infecting human cells, reducing infection rates by nearly 99%.

11 Aug 2025

4,000-year-old sheep tooth sheds light on enigmatic Eurasian plague

Around 5,000 years ago, a mysterious form of plague spread throughout Eurasia, only to disappear 2,000 years later.

11 Aug 2025

New biomarker may be the first specific and quantifiable indicator for confirming long COVID

Researchers from the Translational Genomics Research Institute (TGen), part of City of Hope, and the Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center have identified a potential biomarker for long COVID.

11 Aug 2025

Understanding sex-based differences in immune system function

Many diseases affect men and women differently. Asthma tends to strike men earlier in life, yet more women develop asthma as they get older.

7 Aug 2025

New research pipeline fuels the development of universal vaccines

Most vaccines are designed to provide immunity against just one pathogen. Vaccines for chicken pox (caused by varicella-zoster virus) were only developed to fight that one disease, for example.

7 Aug 2025

Immune surveillance in children sheds light on virus rebound after COVID

The first paper from a multi-year clinical research study has been published in The Lancet Infectious Diseases: Dynamics of Endemic Virus Re-emergence in Children in the USA Following the COVID-19 Pandemic (2022-2023): A Longitudinal Immunoepidemiologic Surveillance Study and demonstrates how the approach can improve modeling to better predict future outbreaks.

7 Aug 2025

Sugarcoating hides cellular RNA from the immune system

To our immune system, naked RNA is a sign of a viral or bacterial invasion and must be attacked. But our own cells also have RNA.

6 Aug 2025

Unraveling the mysteries of post-acute infection syndromes

In recent years, doctors and scientists are increasingly studying long-lasting illnesses that begin after someone recovers from an infection.

1 Aug 2025

New blood test detects early-stage solid tumors with high accuracy

Current methods for cancer diagnosis are based on identifying biomarkers - molecules that reveal a particular state or process in the body – produced by the tumor or associated proteins.

31 Jul 2025

Experimental drug found to be safe and effective in treating children with MIS-C

In a small trial, Mass General Brigham researchers found a drug designed to treat Celiac disease supported a more rapid return to normal activities for patients following COVID.

30 Jul 2025

Respiratory infections can reactivate dormant breast cancer cells

Researchers at the University of Colorado Anschutz Medical Campus, Montefiore Einstein Comprehensive Cancer Center (MECCC), and Utrecht University have found the first direct evidence that common respiratory infections, including COVID-19 and influenza, can awaken dormant breast cancer cells that have spread to the lungs, setting the stage for new metastatic tumors.

30 Jul 2025

UK self-tests overstate accuracy and pose usability risks

Analysis of UK self-tests reveals critical flaws in accuracy claims, highlighting risks and the need for enhanced regulatory standards for consumer safety.

28 Jul 2025